Moreover, studies have demonstrated that small molecule, such as BI2536, and phosphopeptides, and siRNA-mediated inhibition of PLK-1 may trigger both p53-dependent and p53-independent apoptotic pathways to inhibit tumor progression [15–17]. This evidence concerns the gene PLK1 and neoplasm.